首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
COST-UTILITY ANALYSIS OF VALSARTAN VERSUS VALSARTAN PLUS HYDROCHLOROTHIAZIDE IN PATIENTS WITH HYPERTENSION IN THE US
被引:0
|
作者
:
Pednekar, P.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Sci, Philadelphia, PA USA
Univ Sci, Philadelphia, PA USA
Pednekar, P.
[
1
]
机构
:
[1]
Univ Sci, Philadelphia, PA USA
来源
:
VALUE IN HEALTH
|
2018年
/ 21卷
关键词
:
D O I
:
10.1016/j.jval.2018.04.374
中图分类号
:
F [经济];
学科分类号
:
02 ;
摘要
:
PCV52
引用
收藏
页码:S62 / S62
页数:1
相关论文
共 50 条
[41]
Long-term efficacy, safety, and tolerability of valsartan and hydrochlorothiazide in patients with essential hypertension
Chrysant, SG
论文数:
0
引用数:
0
h-index:
0
机构:
Oklahoma Cardiovasc & Hypertens Ctr, Oklahoma City, OK 73132 USA
Chrysant, SG
Wombolt, DG
论文数:
0
引用数:
0
h-index:
0
机构:
Oklahoma Cardiovasc & Hypertens Ctr, Oklahoma City, OK 73132 USA
Wombolt, DG
Feliciano, N
论文数:
0
引用数:
0
h-index:
0
机构:
Oklahoma Cardiovasc & Hypertens Ctr, Oklahoma City, OK 73132 USA
Feliciano, N
Zheng, HJ
论文数:
0
引用数:
0
h-index:
0
机构:
Oklahoma Cardiovasc & Hypertens Ctr, Oklahoma City, OK 73132 USA
Zheng, HJ
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL,
1998,
59
(11):
: 762
-
772
[42]
Combination antihypertensive therapy with valsartan and hydrochlorothiazide in Chinese patients with mild-to-moderate hypertension
Sun, Ning-L.
论文数:
0
引用数:
0
h-index:
0
机构:
Beijing Univ, Peoples Hosp, Dept Cardiol, Beijing 100871, Peoples R China
Fudan Univ, Zhongshan Hosp, Dept Cardiol, Shanghai 200032, Peoples R China
Sun, Ning-L.
Zhu, Jun-R.
论文数:
0
引用数:
0
h-index:
0
机构:
Fudan Univ, Zhongshan Hosp, Dept Cardiol, Shanghai 200032, Peoples R China
Fudan Univ, Zhongshan Hosp, Dept Cardiol, Shanghai 200032, Peoples R China
Zhu, Jun-R.
Zhao, Yanxing
论文数:
0
引用数:
0
h-index:
0
机构:
Novartis Pharmaceut, E Hanover, NJ USA
Fudan Univ, Zhongshan Hosp, Dept Cardiol, Shanghai 200032, Peoples R China
Zhao, Yanxing
Tu, Ying-M.
论文数:
0
引用数:
0
h-index:
0
机构:
Beijing Novartis Pharma Co Ltd, Beijing, Peoples R China
Fudan Univ, Zhongshan Hosp, Dept Cardiol, Shanghai 200032, Peoples R China
Tu, Ying-M.
CURRENT MEDICAL RESEARCH AND OPINION,
2008,
24
(10)
: 2863
-
2871
[43]
Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study
Lacourciere, Yves
论文数:
0
引用数:
0
h-index:
0
机构:
Ctr Hosp Univ Laval, Hypertens Unit, Quebec City, PQ G1V 4G2, Canada
Ctr Hosp Univ Laval, Hypertens Unit, Quebec City, PQ G1V 4G2, Canada
Lacourciere, Yves
Wright, Jackson T., Jr.
论文数:
0
引用数:
0
h-index:
0
机构:
Case Western Reserve Univ, Cleveland, OH 44106 USA
Ctr Hosp Univ Laval, Hypertens Unit, Quebec City, PQ G1V 4G2, Canada
Wright, Jackson T., Jr.
Samuel, Rita
论文数:
0
引用数:
0
h-index:
0
机构:
Novartis Pharmaceut, E Hanover, NJ USA
Ctr Hosp Univ Laval, Hypertens Unit, Quebec City, PQ G1V 4G2, Canada
Samuel, Rita
Zappe, Dion
论文数:
0
引用数:
0
h-index:
0
机构:
Novartis Pharmaceut, E Hanover, NJ USA
Ctr Hosp Univ Laval, Hypertens Unit, Quebec City, PQ G1V 4G2, Canada
Zappe, Dion
Purkayastha, Das
论文数:
0
引用数:
0
h-index:
0
机构:
Novartis Pharmaceut, E Hanover, NJ USA
Ctr Hosp Univ Laval, Hypertens Unit, Quebec City, PQ G1V 4G2, Canada
Purkayastha, Das
Black, Henry R.
论文数:
0
引用数:
0
h-index:
0
机构:
NYU, Sch Med, New York, NY USA
Ctr Hosp Univ Laval, Hypertens Unit, Quebec City, PQ G1V 4G2, Canada
Black, Henry R.
BLOOD PRESSURE MONITORING,
2009,
14
(03)
: 112
-
120
[44]
Combination Therapy with Valsartan and Hydrochlorothiazide Compared to Valsartan Monotherapy in Hypertensive Patients with Left Ventricular Hypertrophy
Vatinian, Susanna
论文数:
0
引用数:
0
h-index:
0
Vatinian, Susanna
Gurgenyan, Svetlana
论文数:
0
引用数:
0
h-index:
0
Gurgenyan, Svetlana
Nikoghosyan, Karine
论文数:
0
引用数:
0
h-index:
0
Nikoghosyan, Karine
CIRCULATION,
2010,
122
(02)
: E168
-
E168
[45]
A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension
Palatini, P
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Naples Federico II, Clin Med 1, Naples, Italy
Palatini, P
Malacco, E
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Naples Federico II, Clin Med 1, Naples, Italy
Malacco, E
Fogari, R
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Naples Federico II, Clin Med 1, Naples, Italy
Fogari, R
Carretta, R
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Naples Federico II, Clin Med 1, Naples, Italy
Carretta, R
Bonaduce, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Naples Federico II, Clin Med 1, Naples, Italy
Bonaduce, D
Bertocchi, F
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Naples Federico II, Clin Med 1, Naples, Italy
Bertocchi, F
Mann, J
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Naples Federico II, Clin Med 1, Naples, Italy
Mann, J
Condorelli, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Naples Federico II, Clin Med 1, Naples, Italy
Condorelli, M
JOURNAL OF HYPERTENSION,
2001,
19
(09)
: 1691
-
1696
[46]
Valsartan plus hydrochlorothiazide: a review of its use since its introduction
Bains, Jujhar
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Tennessee Med Ctr, Dept Cardiol, Knoxville, TN 37920 USA
Univ Tennessee Med Ctr Knoxville, VRG, NOCCR, Knoxville, TN 37920 USA
Bains, Jujhar
Smith, William B.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Tennessee Med Ctr Knoxville, VRG, NOCCR, Knoxville, TN 37920 USA
Univ Tennessee Med Ctr Knoxville, VRG, NOCCR, Knoxville, TN 37920 USA
Smith, William B.
EXPERT OPINION ON PHARMACOTHERAPY,
2011,
12
(12)
: 1975
-
1984
[47]
Telmisartan plus hydrochlorothiazide (80/25 mg) has a greater antihypertensive effect than valsartan plus hydrochlorothiazide (160/25 mg) in patients with stage 1 and 2 hypertension
White, W
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Connecticut, Sch Med, Farmington, CT USA
White, W
Punzi, H
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Connecticut, Sch Med, Farmington, CT USA
Punzi, H
Neutel, J
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Connecticut, Sch Med, Farmington, CT USA
Neutel, J
Davidai, G
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Connecticut, Sch Med, Farmington, CT USA
Davidai, G
Koval, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Connecticut, Sch Med, Farmington, CT USA
Koval, S
Murwin, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Connecticut, Sch Med, Farmington, CT USA
Murwin, D
AMERICAN JOURNAL OF HYPERTENSION,
2005,
18
(05)
: 97A
-
97A
[48]
Effect of high dose valsartan on arterial stiffness in masked hypertension compared with valsartan plus diuretic
Takami, T.
论文数:
0
引用数:
0
h-index:
0
机构:
Clin Jinguumae, Kashihara, Nara, Japan
Clin Jinguumae, Kashihara, Nara, Japan
Takami, T.
JOURNAL OF HYPERTENSION,
2008,
26
: S453
-
S453
[49]
A cost-utility analysis of losartan versus atenolol in the treatment of mild to moderate hypertension
Anis, AH
论文数:
0
引用数:
0
h-index:
0
机构:
Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
Anis, AH
Sun, H
论文数:
0
引用数:
0
h-index:
0
机构:
Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
Sun, H
Singh, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
Singh, S
Woolcott, JC
论文数:
0
引用数:
0
h-index:
0
机构:
Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
Woolcott, JC
Nosyk, B
论文数:
0
引用数:
0
h-index:
0
机构:
Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
Nosyk, B
VALUE IN HEALTH,
2004,
7
(03)
: 323
-
323
[50]
Cost-Utility Analysis of Sacubitril/Valsartan Use Compared With Standard Care in Chronic Heart Failure Patients With Reduced Ejection Fraction in South Korea
Park, Sun-Kyeong
论文数:
0
引用数:
0
h-index:
0
机构:
Sungkyunkwan Univ, Sch Pharm, 2066 Seobu Ro, Suwon 16419, Gyeonggi Do, South Korea
Sungkyunkwan Univ, Sch Pharm, 2066 Seobu Ro, Suwon 16419, Gyeonggi Do, South Korea
Park, Sun-Kyeong
Hong, Sung-Hyun
论文数:
0
引用数:
0
h-index:
0
机构:
Sungkyunkwan Univ, Sch Pharm, 2066 Seobu Ro, Suwon 16419, Gyeonggi Do, South Korea
Sungkyunkwan Univ, Sch Pharm, 2066 Seobu Ro, Suwon 16419, Gyeonggi Do, South Korea
Hong, Sung-Hyun
Kim, HyoJin
论文数:
0
引用数:
0
h-index:
0
机构:
Novartis Korea Ltd, Patient Access, Seoul, South Korea
Sungkyunkwan Univ, Sch Pharm, 2066 Seobu Ro, Suwon 16419, Gyeonggi Do, South Korea
Kim, HyoJin
Kim, Sungju
论文数:
0
引用数:
0
h-index:
0
机构:
Novartis Korea Ltd, Patient Access, Seoul, South Korea
Sungkyunkwan Univ, Sch Pharm, 2066 Seobu Ro, Suwon 16419, Gyeonggi Do, South Korea
Kim, Sungju
论文数:
引用数:
h-index:
机构:
Lee, Eui-Kyung
CLINICAL THERAPEUTICS,
2019,
41
(06)
: 1066
-
1079
←
1
2
3
4
5
→